SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-018542
Filing Date
2019-05-10
Accepted
2019-05-10 16:11:50
Documents
64
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aldx-10q_20190331.htm 10-Q 1485749
2 EX-31.1 aldx-ex311_10.htm EX-31.1 17709
3 EX-31.2 aldx-ex312_8.htm EX-31.2 17875
4 EX-32.1 aldx-ex321_9.htm EX-32.1 10742
  Complete submission text file 0001564590-19-018542.txt   4860514

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aldx-20190331.xml EX-101.INS 877122
6 XBRL TAXONOMY EXTENSION SCHEMA aldx-20190331.xsd EX-101.SCH 43848
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aldx-20190331_cal.xml EX-101.CAL 38797
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aldx-20190331_def.xml EX-101.DEF 140254
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldx-20190331_lab.xml EX-101.LAB 320630
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldx-20190331_pre.xml EX-101.PRE 248149
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36332 | Film No.: 19815025
SIC: 2834 Pharmaceutical Preparations